Ignite Creation Date:
2024-05-05 @ 11:20 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00002127
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
1999-11-02
Brief Title:
A Phase II Parallel Group Randomized Placebo-Controlled Study of the Safety and Efficacy of Thalidomide in Reducing Weight Loss in Adults With HIV Wasting Syndrome
Sponsor:
Celgene Corporation
Organization:
NIH AIDS Clinical Trials Information Service
Organization Data
Organization:
NIH AIDS Clinical Trials Information Service
Class:
INDUSTRY
Study ID:
230A
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Celgene Corporation
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None